THERAGEN ETEX CO.,LTD. Logo

THERAGEN ETEX CO.,LTD.

A biotech firm offering gene analysis and developing personalized cancer drugs.

066700 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 안산시 단원구 산단로 68번길 58(초지동), 안산시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

THERAGEN ETEX CO., LTD. is a biotechnology and pharmaceutical company specializing in genome-based personalized and precision medicine. The company integrates two core capabilities: advanced gene analysis and pharmaceutical development. Its genomics division provides high-level genome sequencing and analysis services, having achieved milestones such as creating the world's first female and tiger genome maps. The pharmaceutical division operates international GMP-certified facilities to manufacture and supply medicines. It focuses on developing a new drug pipeline that includes incrementally modified drugs, orphan drugs, and novel anticancer treatments. A key candidate, Vactosertib, is currently undergoing clinical trials in Korea and the U.S. for various cancers. This synergistic approach positions the company at the forefront of personalized healthcare solutions.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for THERAGEN ETEX CO.,LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-07-30 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 14.3 KB
2025-07-30 00:00
Management Discussion and Analysis
영업실적등에대한전망(공정공시)
Korean 10.6 KB

Automate Your Workflow. Get a real-time feed of all THERAGEN ETEX CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for THERAGEN ETEX CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
MUROMACHI CHEMICALS INC. Logo
A diversified manufacturer of pharmaceuticals, chemical systems, health foods & functional materials.
Japan 4885
MYUNGMOON PHARM CO.,LTD Logo
Develops, manufactures, and commercializes prescription & OTC medicines for global markets.
South Korea 017180
Nanexa AB Logo
Develops long-acting injectables using its proprietary nanotechnology for its own pipeline and partners.
Sweden NANEXA
Nanobiotix Logo
Develops a first-in-class radioenhancer to amplify radiotherapy's effect directly within tumors.
France NANO
Nanoform Finland OYJ Logo
Pharma tech firm engineering nanoparticles to enhance drug performance and development.
Finland NANOFH
NanoGroup S.A. Logo
Develops patented nanotechnology for oncology and transplantology diagnostics and therapies.
Poland NNG
NanoRepro AG Logo
Develops and distributes rapid diagnostic self-tests for early disease detection.
Germany NN6
NATAC Logo
Develops sustainable plant extracts for nutraceutical, pharma, food, and animal nutrition industries.
Spain NAT
Biotech R&D of natural ingredients for health and wellness solutions.
South Korea 168330
Naturland Holding PLC Logo
A Hungarian company providing full-scale pharmaceutical manufacturing from R&D to sales.
United Kingdom NATUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.